Paradigm Biocapital Advisors LP 13D and 13G filings for Y-mAbs Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:32 pm Purchase | 2024-09-30 | 13G | Y-mAbs Therapeutics, Inc. YMAB | Paradigm Biocapital Advisors LP | 4,086,346 9.200% | 1,888,034 (+85.89%) | Filing |
| 2024-04-08 5:09 pm Purchase | 2024-03-27 | 13G | Y-mAbs Therapeutics, Inc. YMAB | Paradigm Biocapital Advisors LP | 2,198,312 5.020% | 2,198,312 (New Position) | Filing |